BRIEF published on 08/13/2024 at 13:05, 25 days 13 hours ago Bausch Health annonce les lauréats du programme de bourses d'études en santé gastro-intestinale 2024 Bausch Santé Santé Gastro-intestinale Enseignement Supérieur Programme De Bourses D'études Produits Pharmaceutiques Salix
BRIEF published on 08/13/2024 at 13:05, 25 days 13 hours ago Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners Salix Pharmaceuticals Bausch Health Higher Education Gastrointestinal Health Scholarship Program
PRESS RELEASE published on 08/13/2024 at 13:00, 25 days 13 hours ago Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners Bausch Health and Salix Pharmaceuticals announce 2024 Salix Gastrointestinal Health Scholars Program recipients, providing $10,000 each to 10 students with GI disease for higher education Salix Pharmaceuticals Bausch Health Education Gastrointestinal Disease Scholarship Program
BRIEF published on 07/31/2024 at 06:05, 1 month 7 days ago Bausch Health publie ses résultats financiers du deuxième trimestre 2024 Résultats Financiers EBITDA Ajusté Hausse Des Revenus Bausch Santé Performances Sectorielles
BRIEF published on 07/31/2024 at 06:05, 1 month 7 days ago Bausch Health Reports Second Quarter 2024 Fiscal Performance Financial Results Adjusted EBITDA Revenue Growth Bausch Health Segment Performance
PRESS RELEASE published on 07/31/2024 at 06:00, 1 month 7 days ago Bausch Health Announces Second Quarter 2024 Results Bausch Health announced second quarter 2024 financial results with $2.40 billion revenues, 11% increase. Raised full-year Revenue and Adjusted EBITDA guidance Revenues Financial Results EBITDA Bausch Health Guidance
BRIEF published on 07/24/2024 at 18:55, 1 month 14 days ago Bausch Health Responds to Market Rumors Bausch Health Bankruptcy Financial Stability Market Rumors Reorg Update
BRIEF published on 07/24/2024 at 18:55, 1 month 14 days ago Bausch Health répond aux rumeurs du marché Bausch Santé Stabilité Financière La Faillite Rumeurs De Marché Mise À Jour De La Réorganisation
PRESS RELEASE published on 07/24/2024 at 18:50, 1 month 14 days ago Bausch Health Responds to Market Rumors Bausch Health refutes rumors of bankruptcy discussions. The global pharmaceutical company emphasizes its commitment to delivering better healthcare outcomes Pharmaceutical Company Healthcare Outcomes Bausch Health Bankruptcy Rumors
BRIEF published on 07/19/2024 at 13:05, 1 month 19 days ago Bausch Health Welcomes Two New Members to the Executive Leadership Team Pharmaceutical Industry Bausch Health Financial Leadership Executive Leadership Corporate Appointments
Published on 09/07/2024 at 01:30, 1 day 1 hour ago Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
Published on 09/07/2024 at 00:30, 1 day 2 hours ago Cheech and Chong’s Global Holding Company Responds to California’s Proposed Emergency Hemp Ban
Published on 09/06/2024 at 23:15, 1 day 3 hours ago BluSky Carbon Announces Extension of Strategic Marketing Agreement
Published on 09/07/2024 at 14:00, 12 hours 42 minutes ago Litigation costs drive US liability claims by 57% over past decade, reveals Swiss Re Institute
Published on 09/06/2024 at 22:00, 1 day 4 hours ago Successful completion of preset purchase plan for the acquisition of Northern Data Group shares by CEO Aroosh Thillainathan
Published on 09/06/2024 at 18:45, 1 day 7 hours ago Molten Ventures Plc: POS-Transaction in Own Shares
Published on 09/06/2024 at 18:15, 1 day 8 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/06/2024 at 17:56, 1 day 8 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/06/2024 at 18:00, 1 day 8 hours ago Declaration of voting rights at the end of August 2024